DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Adli M, Philhatsch M, Bauer M et al.
Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistent depression.
Pharmacopsychiatry 2008;
41: 252-257
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.